Surkova E V
Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia.
Ter Arkh. 2016;88(10):82-86. doi: 10.17116/terarkh201688682-86.
The review considers the current views on the central nervous system (CNS) in diabetes mellitus (DM). It discusses an attitude towards the term 'diabetic encephalopathy'. The data of investigations of cognitive functions in types 1 and 2 DM and the brain structural imaging results obtained using up-to-date technologies are considered. The results of studies of the factors that induce cerebral changes in DM and their associated cognitive impairments are given. There is evidence that hyperglycemia has a more considerable impact on the above processes than hypoglycemia; other possible factors, apart from blood glucose control, are set out. The current views on the function of insulin in the CNS and the relationship of central insulin resistance to Alzheimer's disease are outlined. There are current data on intranasal insulin application that is still exploratory, but, as might be judged from the findings, may by a promising method for the treatment and prevention of cognitive decline in both patients with DM and those without this condition.
本综述探讨了当前对糖尿病(DM)中枢神经系统(CNS)的看法。讨论了对“糖尿病性脑病”这一术语的态度。考虑了1型和2型糖尿病认知功能的调查数据以及使用最新技术获得的脑结构成像结果。给出了糖尿病中诱发脑部变化及其相关认知障碍的因素的研究结果。有证据表明,高血糖对上述过程的影响比低血糖更大;除血糖控制外,还列出了其他可能的因素。概述了目前对中枢神经系统中胰岛素功能的看法以及中枢胰岛素抵抗与阿尔茨海默病的关系。目前有关于鼻内应用胰岛素的数据,该应用仍处于探索阶段,但从研究结果来看,可能是治疗和预防糖尿病患者及非糖尿病患者认知衰退的一种有前景的方法。